The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

计划入组 50 人 · 首次发布于 2020 年 11 月 12 日

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

计划入组 26,758 人 · 首次发布于 2019 年 10 月 30 日

Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"

计划入组 23,494 人 · 首次发布于 2019 年 10 月 30 日

MT-5111

MT-1006

MT-5562

John Muir Physician Network

United States

森飞医药科技（重庆）有限公司

哈尔滨拜仑斯特临床营养有限公司

Exact Sciences Presents Data on Cologuard Plus and Adherence Strategies at ACG 2024

Marker Therapeutics Reports Positive Clinical Outcomes for MT-601 in Lymphoma Patients

Myeloid Therapeutics' MT-303, a Novel mRNA CAR Therapy, Enters Phase 1 Trial for Liver Cancer